These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
☒
Filed by a Party other than the Registrant
☐
|
||||||||
|
Check the appropriate box:
|
||||||||
| ☐ | Preliminary Proxy Statement | |||||||
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||
| ☒ | Definitive Proxy Statement | |||||||
| ☐ | Definitive Additional Materials | |||||||
| ☐ | Soliciting Material Under §240.14a-12 | |||||||
|
Payment of Filing Fee (Check all boxes that apply):
|
||||||||||||||
| ☒ | No fee required. | |||||||||||||
| ☐ | Fee paid previously with preliminary materials. | |||||||||||||
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. | |||||||||||||
| GLOBAL REACH, LOCAL INSIGHTS | ||||||||
| Nearly | ||||||||
| One | 26 | 1,850 | ||||||
| Global, diversified platform | Offices | People globally | ||||||
| AMERICAS | NEW YORK | EUROPE | MILAN | LONDON | HONG KONG | TOKYO | ||||||||||||||
| LOS ANGELES | SAN FRANCISCO | PARIS | LUXEMBOURG | ASIA | SHANGHAI | SEOUL | ||||||||||||||
| MIAMI | WASHINGTON, DC | MUNICH | AMSTERDAM | DUBAI | MUMBAI | SINGAPORE | ||||||||||||||
| MENLO PARK | LIMA | DUBLIN | BARCELONA | BEIJING | JAKARTA | SYDNEY | ||||||||||||||
| DATE & TIME | 9:00 a.m. EDT | ||||
| Tuesday, May 31, 2022 | |||||
| ACCESS* | Our Annual Meeting can be accessed virtually at: | ||||
| www.virtualshareholdermeeting.com/CG2022 | |||||
| RECORD DATE | April 4, 2022. A list of shareholders as of the record date will be accessible electronically during the Annual Meeting at www.virtualshareholdermeeting.com/CG2022 when you enter your 16-Digit Control Number. | ||||
|
Important Notice Regarding the Availability of Proxy Materials for our Annual Meeting to be held on Tuesday, May 31, 2022. Our Proxy Statement and 2021 Annual Report to Shareholders are available at www.proxyvote.com. On or about April 13, 2022, we will send to certain of our shareholders a Notice of Internet Availability of Proxy Materials (“Notice”). The Notice includes instructions on how to access our Proxy Statement and 2021 Annual Report to Shareholders and vote online. For more information, see
Frequently Asked Questions.
|
||
|
This proxy may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, but are not limited to, statements related to our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, contingencies, our dividend policy, and other non-historical statements. You can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements including, but not limited to, those described under the section entitled “Risk Factors” in our Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on February 10, 2022, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this report and in our other periodic filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.
|
||
|
CARLYLE
Proxy Statement 2022
|
1
|
||||
|
||
|
BOARD
RECOMMENDATION
|
PAGE | |||||||
|
ITEM 1.
Election to our Board of Directors of the four Class II director nominees named in the accompanying Proxy Statement for a three-year term
|
FOR each director | |||||||
|
ITEM 2.
Ratification of Ernst & Young as Independent Registered Public Accounting Firm for 2022
|
FOR | |||||||
|
ITEM 3.
Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”)
|
FOR | |||||||
|
ITEM 4.
Shareholder Proposal to Reorganize the Board of Directors into One Class
|
FOR | |||||||
|
01.
|
|
02.
|
|
03.
|
|
||||||||||||||||||
|
Accelerate scope and scale of investment platform
|
Capitalize on new opportunities through adjacencies
|
Institutionalize
the firm |
|||||||||||||||||||||
| Ç | Ç | Ç | |||||||||||||||||||||
| DRIVE EARNINGS GROWTH AND LONG-TERM SHAREHOLDER VALUE | |||||||||||||||||||||||
|
2
|
CARLYLE
Proxy Statement 2022
|
||||
| $4.0 Billion | $598 Million | $2.2 Billion | ||||||||||||
| In Income Before Provision for Income Taxes, reflecting an income before provision for income taxes margin of 46% | In Fee Related Earnings, reflecting an FRE Margin of 33%* | In Distributable Earnings* | ||||||||||||
| $33.8 Billion | $301 Billion | $51.3 Billion | ||||||||||||
|
In Invested Capital (carry funds),
up 85% year over year
|
In Assets Under Management,
up 22% year over year
|
In Fundraising | ||||||||||||
| 23% | 31% | 13% | ||||||||||||
| Global Private Equity AUM growth year over year, record FRE of $402 million | Global Credit AUM growth year over year, record FRE of $112 million | Global Investment Solutions AUM growth year over year, more than doubled FRE to $84 million | ||||||||||||
|
CARLYLE
Proxy Statement 2022
|
3
|
||||
|
4
|
CARLYLE
Proxy Statement 2022
|
||||
| Developed the | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Energy + |
Four
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Carbon | straight years of carbon neutrality as a firm | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Management Playbook | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Launched the
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| ESG Data Convergence Project | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Completed
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
+$12 Billion
|
2021 PE Innovators in ESG
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| in ESG-linked financings | by Mergers & Acquisitions Magazine | |||||||||||||||||||||||||||||||||||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
5
|
||||
|
6
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
7
|
||||
| Form | Compensation Element | Description | |||||||||
|
BASE SALARY
|
Fixed salary paid bi-weekly
|
|||||||||
|
ANNUAL CASH PERFORMANCE AWARDS
|
CEO
2 components:
•
Formulaic bonus calculated with reference to the annual dividend paid to shareholders
•
Incentive bonus based on goals determined and evaluated annually by the Compensation Committee (including the achievement of certain strategic initiatives, employee engagement, leadership and exemplification of the values of our firm, succession planning, diversity and inclusion and ESG efforts and Fee Related Earnings (“FRE”) margin improvement)
|
||||||||||
|
Other Named Executive Officers
Bonus paid based on assessment of overall firm, investment fund and individual performance
|
|||||||||||
|
TIME-VESTING RESTRICTED STOCK UNITS
|
CEO
None awarded in 2021.
Other Named Executive Officers (Other Than Mr. Clare)
RSUs that are eligible to vest over 3.5 to 4 years
|
|||||||||
|
PERFORMANCE-VESTING RESTRICTED STOCK
UNITS
|
CEO and Other Named Executive Officers
Performance-vesting RSU awards that vest based on achievement of one or more of the following financial performance metrics:
•
FRE
•
Realized Net Performance Revenues (“RNPR”)
•
Fee-Earning Assets Under Management Raised (“FEAUM Raised”)
•
Adjusted FRE for the Global Private Equity segment
Payout for certain of these awards capped at 150% if certain stock price conditions are not satisfied
|
||||||||||
|
WHAT WE DO:
|
WHAT WE DO NOT DO:
|
||||||||||||||||
Align pay with firmwide performance, including through use of time-vesting and performance-vesting RSUs
Large majority of compensation is variable, and the majority is delivered in equity
Long-term incentive awards are denominated and settled in equity
Prohibit short sales and derivative transactions in our equity and hedging of our stock and generally prohibit pledging of our stock
Regularly engage with current and potential shareholders
Engage an independent compensation consultant that works directly for our Compensation Committee and does no work for management
Tie incentive compensation to a clawback policy that covers financial restatements
Require our executive officers to own a minimum value of shares of our common stock
Hold an annual Say-on-Pay vote
Perform an annual compensation risk assessment
Require performance at the 66th percentile of relative TSR in order to receive the target payout under our CEO’s TSR-based outperformance awards, and provide for forfeiture of such awards for performance below the 50th percentile of relative TSR
For new equity incentive awards granted in 2022, require a qualifying termination of employment following a change in control of Carlyle in order for any such change in control to trigger accelerated vesting rights
|
No excise tax “gross-up” payments in the event of a change in control
No tax “gross-up” payment in perquisites for named executive officers
No dividends or dividend equivalents accrued or paid on unvested equity awards
No supplemental executive retirement benefits
|
||||||||||||||||
|
8
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
|
After a review of the individual qualifications and experiences of each of our director nominees and their contributions to our Board, our Board determined unanimously to recommend that shareholders vote
“FOR”
the four Class II nominees named in this Proxy Statement.
|
||
|
CARLYLE
Proxy Statement 2022
|
9
|
||||
|
DAVID M. RUBENSTEIN,
Founder, Co-Chairman and Director
Age:
72
Director Since:
2011
|
||||
|
Mr. Rubenstein is a co-founder and non-executive Co-Chairman of the Board. Mr. Rubenstein was elected to our Board of Directors effective July 18, 2011. Previously, Mr. Rubenstein served as Co-Chief Executive Officer of Carlyle. Among other philanthropic endeavors, Mr. Rubenstein is Chairman of the Boards of the John F. Kennedy Center for the Performing Arts, the Council on Foreign Relations, the National Gallery of Art and the Economic Club of Washington; a fellow of the Harvard Corporation; a trustee of the University of Chicago, Memorial Sloan-Kettering Cancer Center, Johns Hopkins Medicine, the Institute for Advanced Study, the National Constitution Center, the Brookings Institution and the World Economic Forum; and a Director of the Lincoln Center for the Performing Arts and the American Academy of Arts and Sciences. Mr. Rubenstein is the host of The David Rubenstein Show and Bloomberg Wealth with David Rubenstein; and the author of The American Story, How to Lead, and The American Experiment. Mr. Rubenstein is a magna cum laude graduate of Duke University, where he was elected Phi Beta Kappa. Following Duke, Mr. Rubenstein graduated from The University of Chicago Law School, where he was an editor of The Law Review.
|
|||||
|
LINDA
H. FILLER,
Director
Age: 62
Director Since:
2022
Committees:
Nominating and Corporate Governance Committee
|
||||
|
Ms. Filler is a member of our Board of Directors. Ms. Filler was elected to our Board of Directors effective April 1, 2022. Ms. Filler retired as President of Retail Products, Chief Marketing Officer, and Chief Merchandising Officer at Walgreen Co. in 2017. Prior to Walgreen Co, Ms. Filler served in Executive Vice President roles at Walmart and at Kraft Foods. Prior to Kraft, Ms. Filler served a long tenure at Hanes Brands, including Group CEO roles of its largest branded apparel businesses. Ms. Filler is Lead Independent Director at Danaher Corporation, where she has served as a Director since 2004. She serves as Chair of the Nominating & Governance Committee and on the Science & Technology Committee. Ms. Filler also serves on the Board of Eversight, a leader in AI-based price and promotion optimization for consumer goods companies and retailers. Ms. Filler serves as Chair of the Development Committee for the Chicago Public Library Foundation, and on the Foundation’s Executive Committee, among other philanthropic activities. Ms. Filler earned an MBA from Harvard Business School and an MS from the University of North Texas.
|
|||||
|
10
|
CARLYLE
Proxy Statement 2022
|
||||
|
JAMES
H. HANCE, JR.,
Operating Executive and Director
Age:
77
Director Since:
2012
|
||||
|
Mr. Hance is an Operating Executive of Carlyle and a member of our Board of Directors. Mr. Hance was elected to our Board of Directors effective May 2, 2012. Mr. Hance joined Carlyle in November 2005 as an Operating Executive and has worked primarily in our Global Credit segment and the financial services sector. Prior to joining Carlyle in 2005, Mr. Hance served as Vice Chairman of Bank of America from 1993 until his retirement on January 31, 2005 and served as Chief Financial Officer from 1988 to 2004. Prior to joining Bank of America, Mr. Hance spent 17 years with Price Waterhouse (now Pricewaterhouse Coopers LLP). Mr. Hance is currently a director of Acuity Brands Inc. (where he serves as the Lead Independent Director and on the Audit Committee and Governance Committee). Mr. Hance is a former director of Ford Motor Company, Sprint Nextel Corporation, Morgan Stanley, Duke Energy Corporation, Cousins Properties, Parkway, Inc. and Bank of America Corporation. Mr. Hance serves as Emeritus Trustee on the Board of Trustees at Washington University in St. Louis and as Chairman of the Board of Trustees at Johnson & Wales University in Providence, RI. Mr. Hance graduated from Westminster College and received an MBA from Washington University in St. Louis. He is a certified public accountant.
|
|||||
|
DERICA
W. RICE,
Director
Age:
57
Director Since:
2021
Committees:
Audit Committee, Compensation Committee
|
||||
|
Mr. Rice is a member of our Board of Directors. Mr. Rice was appointed to our Board of Directors effective March 8, 2021. Mr. Rice served as executive vice president of CVS Health and President of CVS Caremark, the pharmacy benefits management business of CVS Health, from March 2018 to February 2020. Previously, he held various executive positions at Eli Lilly and Company, most recently executive vice president of Global Services and chief financial officer from 2006 to 2017. Mr. Rice is currently a director of Bristol-Meyers Squibb Company (where he serves on the Audit Committee and the Compensation and Management Development Committee), Target Corporation (where he serves on the Audit and Finance Committee and the Infrastructure and Investment Committee) and The Walt Disney Company (where he serves on the Audit Committee). Mr. Rice received his Bachelor of Science degree in Electrical and Electronics Engineering from Kettering University and an MBA from Indiana University.
|
|||||
|
KEWSONG
LEE,
Chief Executive Officer and Director
Age:
56
Director Since:
2018
|
||||
|
Mr. Lee is the Chief Executive Officer of Carlyle and was elected to the Board of Directors effective January 1, 2018. Mr. Lee joined Carlyle in 2013 as Deputy Chief Investment Officer for Corporate Private Equity and in 2016 he assumed the additional role of leading the Global Credit segment. Prior to joining Carlyle, Mr. Lee was a partner and a member of the Executive Management Group at Warburg Pincus, where he spent 21 years. He currently serves as the President of the Lincoln Center Theater, Chairman of the US Chamber of Commerce China Center and Vice Chair of the Partnership for New York City. He also is a member of the Business Roundtable, serves on the board of FCLT Global, and is a Trustee of the Center for Strategic and International Studies. Mr. Lee earned his AB in applied mathematics in economics at Harvard College and his MBA from Harvard Business School.
|
|||||
|
CARLYLE
Proxy Statement 2022
|
11
|
||||
|
WILLIAM
E. CONWAY, JR.,
Founder, Co-Chairman and Director
Age:
72
Director Since:
2011
|
||||
|
Mr. Conway is a co-founder and non-executive Co-Chairman of the Board. Mr. Conway was elected to our Board of Directors effective July 18, 2011. Previously, Mr. Conway served as our Co-Chief Executive Officer and Chief Investment Officer. Prior to forming Carlyle in 1987, Mr. Conway was the Senior Vice President and Chief Financial Officer of MCI Communications Corporation (“MCI”). Mr. Conway was a Vice President and Treasurer of MCI from 1981 to 1984. Mr. Conway is Chairman of the Board of Trustees of Johns Hopkins Medicine and a member of the Board of Trustees of the Catholic University of America. He previously served as chairman and/or director of several public and private companies in which Carlyle had significant investment interests. Mr. Conway received his BA from Dartmouth College and his MBA in finance from The University of Chicago Booth School of Business.
|
|||||
|
LAWTON
W. FITT,
Lead Independent Director
Age:
68
Director Since:
2012
Committees:
Audit Committee, Compensation Committee,
Nominating and Corporate Governance Committee (Chair)
|
||||
|
Ms. Fitt is a member of our Board of Directors, and serves as our Lead Independent Director. Ms. Fitt was elected to our Board of Directors effective May 2, 2012. Ms. Fitt served as Secretary (CEO) of the Royal Academy of Arts in London from October 2002 to March 2005. Prior to that, Ms. Fitt was a partner with Goldman Sachs & Co. Ms. Fitt is currently a director of Ciena Corporation (where she serves as chair of the Audit Committee), Micro Focus International (where she serves on the Audit Committee, Remuneration Committee, and Nominating Committee) and The Progressive Corporation (where she serves as Chairperson, and serves on the Investment and Capital Committee and as chair of the Nominating and Governance Committee). Ms. Fitt is a former director of ARM Holdings PLC and Thomson Reuters. She is also a trustee or director of several not-for-profit organizations including the Goldman Sachs Foundation. Ms. Fitt earned her AB in history at Brown University and her MBA from the Darden School of the University of Virginia.
|
|||||
|
MARK
S.
ORDAN,
Director
Age: 63
Director Since:
2022
Committees:
Compensation Committee
|
||||
|
Mr. Ordan is a member of our Board of Directors. Mr. Ordan was elected to our Board of Directors effective April 1, 2022. Mr. Ordan joined Mednax in July 2020 and currently serves as Chief Executive Officer. Previously, Mr. Ordan founded and served as Chief Executive Officer of Quality Care Properties, Inc. from 2016 to 2018. In July 2018, he completed a sale of the company to Welltower and Promedica. Before that, Mr. Ordan served as Chief Executive Officer of Washington Prime Group Inc. from 2014 to 2015, from its inception as a spin-off of the Simon Property Group. From 2008 to 2013, Mr. Ordan served as Chief Executive Officer of Sunrise Senior Living, Inc. where he led the company’s turnaround and restructuring and oversaw the sale of the company in January 2013. From 2006 to 2007, he served as Chief Executive Officer of The Mills Corporation, which he sold to Simon Property Group and Farrallon. Mr. Ordan holds a bachelor’s degree in philosophy from Vassar College. He received a master’s degree in business administration from Harvard Business School. Additionally, he is a recipient of the Hitchcock Humanitarian Award from the Cystic Fibrosis Foundation and is an inductee of the Washington Business Hall of Fame. Mr. Ordan currently serves on the Board of Directors of Mednax, Federal Realty Investment Trust and Vassar College. Additionally, he serves as Vice Chairman of the Board for the U.S. Chamber of Commerce.
|
|||||
|
12
|
CARLYLE
Proxy Statement 2022
|
||||
|
ANTHONY
WELTERS,
Director
Age:
67
Director Since:
2015
Committees:
Compensation Committee (Chair),
Nominating and Corporate Governance Committee
|
||||
|
Mr. Welters joined our Board on October 27, 2015. He is Founder, Chairman and CEO of CINQ Care Inc., a physician-led, community-based ambulatory care delivery system that delivers whole person care in the home, whenever possible, to Black and Brown communities. He is Executive Chairman of the BlackIvy Group, an organization focused on building and growing commercial enterprises in Sub-Saharan Africa, and Chairman of Somatus, Inc., a value-based kidney care company. Mr. Welters founded AmeriChoice in 1989 and upon acquisition by UnitedHealth Group (UHG) in 2002, joined UHG serving as Senior Adviser to the Office of the CEO, Executive Vice President and Member of the Office of the CEO, retiring in 2016. He currently serves on the public boards of Loews Corporation and Gilead Sciences, Inc. Mr. Welters is Trustee Emeritus of Morehouse School of Medicine Board of Trustees, Chairman Emeritus of the Board of New York University School of Law, Vice Chairman of the Board of New York University, a Trustee of NYU Langone Medical Center, Vice Chair of the John F. Kennedy Center for the Performing Arts and a founding member of the National Museum of African American History and Culture.
|
|||||
|
DANIEL
A. D’ANIELLO,
Founder, Chairman Emeritus and Director
Age:
75
Director Since:
2011
|
||||
|
Mr. D’Aniello is a co-founder and Chairman Emeritus of Carlyle. He has served on our Board of Directors since the Board’s inception on July 18, 2011, serving as Chairman from 2012 until January 1, 2018. Prior to forming Carlyle in 1987, Mr. D’Aniello was the Vice President for Finance and Development at Marriott Corporation for eight years. Before joining Marriott, Mr. D’Aniello was a financial officer at PepsiCo, Inc. and Trans World Airlines. Mr. D'Aniello served in the United States Navy from 1968 through 1971 during which time he was a Distinguished Naval Graduate of Officer Candidate School, Newport R.I.; a Supply Officer (LTJG) aboard the USS Wasp (CVS 18); and in 2016, Mr. D'Aniello was awarded the designation of Lone Sailor by the U.S. Navy Memorial Foundation. Mr. D’Aniello is Chairman of the American Enterprise Institute for Public Research; Co-Chairman of the Institute for Veterans and Military Families; Chairman of the Wolf Trap Foundation of the Performing Arts; an Advisor to the John Templeton Foundation; a founding Trustee of the Lumen Institute; and a Lifetime Member of the Board of Trustees of Syracuse University, a member of the Chancellor’s Council and the Corporate Advisory Council to the Martin J. Whitman School of Management. Mr. D’Aniello previously served as chairman and/or director of several private and public companies in which Carlyle had significant investment interests. Mr. D’Aniello is a 1968 magna cum laude graduate of Syracuse University, where he was a member of Beta Gamma Sigma, and a 1974 graduate of the Harvard Business School, where he was a Teagle Foundation Fellow.
|
|||||
|
CARLYLE
Proxy Statement 2022
|
13
|
||||
|
PETER J. CLARE,
Chief Investment Officer of Corporate Private Equity, Chairman of the Americas and Director
Age:
57
Director Since:
2018
|
||||
|
Mr. Clare is a member of our Board of Directors. Mr. Clare was elected to our Board of Directors effective January 1, 2018. Mr. Clare is the Chief Investment Officer of Corporate Private Equity, Chairman of the Americas and Chair of the US Buyout and Growth Investment committees. Mr. Clare previously served as the Co-Head of the US Buyout and Growth team and as Deputy Chief Investment Officer of the Company’s CPE segment. From 1999 to 2001, Mr. Clare was based in Hong Kong and was a founding member of the Carlyle Asia Buyout team and continues to serve on the Carlyle Asia Buyout Investment Committee. In 2001 and 2002, Mr. Clare launched Carlyle’s initial investments in distressed debt, which led to the creation of Carlyle Strategic Partners. From 2004 to 2011, Mr. Clare served as the Global Head of the Aerospace, Defense & Government Services sector team. Prior to joining Carlyle, Mr. Clare was with First City Capital Corporation, a private equity group that invested in buyouts, public equities, distressed bonds and restructurings. Prior to joining First City Capital, he was with the Merchant Banking Group of Prudential‑Bache. Mr. Clare currently serves as a member of the Board of Directors of Sedgwick Claims Management. Mr. Clare has previously served on the boards of Booz Allen Hamilton, CommScope, Inc., Nouryon, Pharmaceutical Product Development (PPD), Sequa and Signode Industrial. Mr. Clare is a magna cum laude graduate of Georgetown University and received his MBA from the Wharton School at the University of Pennsylvania.
|
|||||
|
DR. THOMAS S. ROBERTSON,
Director
Age:
79
Director Since:
2012
Committees:
Audit Committee
|
||||
|
Dr. Robertson is a member of our Board of Directors. Dr. Robertson was elected to our Board of Directors effective May 2, 2012. Dr. Robertson was the Dean of The Wharton School from 2007 to 2014. Since then he has been the Joshua J. Harris Professor of Marketing at The Wharton School where he holds the positions of Academic Director of the Baker Retailing Center and Executive Director of the Wharton INSEAD Alliance. Previously, Dr. Robertson was Dean of Emory University’s Goizueta Business School from 1998 to 2007. He also served as Special Assistant to Emory University’s president on issues of international strategy and was a founding director of the Institute for Developing Nations, which was established jointly by Emory University and The Carter Center in fall 2006. Before joining Emory, Dr. Robertson was the Sainsbury Professor and Chair of the Marketing Department and Deputy Dean of the London Business School from 1994 to 1998. He also served as a member of the Marketing faculty at The Wharton School from 1971 to 1994 and was the Associate Dean for Executive Education. Dr. Robertson is currently on the Advisory Board of The Sorbonne Universities and is a former director of CRA International, Inc. and PRGX Global, Inc. He graduated from Wayne State University and received his M.A. in Sociology and Ph.D. in Marketing from Northwestern University.
|
|||||
|
14
|
CARLYLE
Proxy Statement 2022
|
||||
|
WILLIAM J. SHAW,
Director
Age:
76
Director Since:
2012
Committees:
Audit Committee (Chair)
|
||||
|
Mr. Shaw is a member of our Board of Directors. Mr. Shaw was elected to our Board of Directors effective May 2, 2012. Mr. Shaw was the Vice Chairman of Marriott International, Inc. until his retirement in March 2011. Prior to becoming Vice Chairman of Marriott, Mr. Shaw served as President and Chief Operating Officer of Marriott from 1997 until 2009. Mr. Shaw joined Marriott in 1974 and held various positions, including Corporate Controller, Corporate Vice President, Senior Vice President‑Finance, Treasurer, Chief Financial Officer, Executive Vice President and President of Marriott Service Group. Prior to joining Marriott, Mr. Shaw worked at Arthur Andersen & Co. Mr. Shaw is Chairman of the Board of Directors of Marriott Vacations Worldwide Corporation, a Director of DiamondRock Hospitality (where he serves as Chairman of the Audit Committee and serves on the Compensation Committee and Nominating and Corporate Governance Committee) and is a former member of the Board of Trustees of three funds in the American Family of mutual funds from 2009 to 2015. Mr. Shaw serves on the Board of Trustees of the University of Notre Dame. Mr. Shaw graduated from the University of Notre Dame and received an MBA from Washington University in St. Louis.
|
|||||
|
CARLYLE
Proxy Statement 2022
|
15
|
||||
| Board Diversity Matrix (As of April 13, 2022) | |||||||||||||||||||||||
| Total Number of Directors | 13 | ||||||||||||||||||||||
| Gender Identity | Female | Male | Non-Binary | Did Not Disclose Gender | |||||||||||||||||||
| Directors | 2 | 11 | — | — | |||||||||||||||||||
| Demographic Background | |||||||||||||||||||||||
| African American or Black | — | 2 | — | — | |||||||||||||||||||
| Alaskan Native or Native American | — | — | — | — | |||||||||||||||||||
| Asian | — |
1
|
— | — | |||||||||||||||||||
| Hispanic or Latinx | — | — | — | — | |||||||||||||||||||
| Native Hawaiian or Pacific Islander | — | — | — | — | |||||||||||||||||||
| White | 2 | 8 | — | — | |||||||||||||||||||
| Two or More Races or Ethnicities | — | — | — | — | |||||||||||||||||||
| LGBTQ+ | — | ||||||||||||||||||||||
| Did Not Disclose Demographic Background | — | ||||||||||||||||||||||
|
DIRECTOR ATTRIBUTES
|
All our Directors possess the following attributes: | |||||||
|
•
Dedication to integrity and excellence
•
Commitment to sustainability
•
Global perspective
•
Proven track record of success
|
•
Risk oversight experience
•
Experience with corporate governance requirements
•
CEO, Senior Leadership or other relevant leadership experience
|
|||||||
|
16
|
CARLYLE
Proxy Statement 2022
|
||||
|
•
Mr. Lee
— We considered his business acumen, innovative thinking, leadership experience in a variety of senior roles at financial institutions and substantial global business experience.
•
Messrs. Conway, D’Aniello and Rubenstein
— We considered that these three individuals are the original founders of our firm, that each has played an integral role in our firm’s successful growth since its founding in 1987, and that each has developed a unique and unparalleled understanding of our business. Finally, we also noted that these three individuals are our largest equity owners and, as a consequence of such alignment of interest with our other equity owners, each has additional motivation to diligently fulfill his oversight responsibilities as a member of the Board.
•
Mr. Clare
— We considered his extensive investment and leadership experience as the former co-head of our U.S. Buyout business, Chief Investment Officer of CPE, Chairman of the Americas and Chair of the U.S. Buyout and Growth investment committees.
•
Ms. Fitt
— We considered her extensive financial background and experience in a distinguished career at Goldman Sachs in the areas of investment banking and risk analysis, including her unique insights into the operation of global capital markets.
•
Mr. Hance
— We considered his invaluable perspective owing to his experience in various senior leadership roles in the financial services industry, including his role as the Chief Financial Officer of Bank of America Corporation, which included responsibility for financial and accounting matters, as well as his familiarity with our business and operations as an Operating Executive of Carlyle.
|
•
Mr. Rice
— We considered his experience with complex, global business operations, and extensive knowledge of a wide range of financial and accounting matters resulting from his distinguished career at CVS Health and Eli Lilly and Company.
•
Dr. Robertson
— We considered his distinguished career as a professor and Dean of the Wharton School at the University of Pennsylvania and his extensive knowledge and expertise in finance and business administration.
•
Mr. Shaw
— We considered his extensive financial background and public company operating and management experience resulting from his distinguished career in various senior leadership roles at Marriott.
•
Mr. Welters
— We considered his business acumen and entrepreneurial experience, extensive operating expertise as well as his familiarity with board responsibilities, oversight and control resulting from his significant experience serving on
the boards of directors of various public companies.
•
Ms. Filler
— We considered her extensive experience in senior management role and expertise in marketing and branding and corporate strategy, as well as her experience as a director of a large, global business.
•
Mr. Ordan
— We considered his extensive leadership experience from serving as the CEO of various companies and resulting in considerable operational knowledge, as well as his prior experience as a director of other public company boards.
|
|||||||
|
CARLYLE
Proxy Statement 2022
|
17
|
||||
|
18
|
CARLYLE
Proxy Statement 2022
|
||||
| 1 |
|
2 |
|
3 |
|
4 |
|
5 |
|
6 | |||||||||||||||||||||||||||||||||||||
| Strategy |
Risk
Management |
CEO
Performance |
Human Capital
Management |
Culture &
Values
|
|
ESG &
Impact
|
|||||||||||||||||||||||||||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
19
|
||||
|
BOARD OVERSIGHT
•
Our Board is responsible for oversight of the firm’s enterprise risk management strategy and its risk tolerance.
•
Other areas of risk management addressed by the Board include global and regional market dynamics, political and legislative risk, environmental and social risk, and technology and cyber-security risk. While the full Board exercises responsibility for enterprise risk management, each Board committee maintains appropriate risk oversight within the scope of its committee function.
|
||||||||||||||
|
AUDIT COMMITTEE
•
Undertakes oversight of financial, tax, legal and compliance risks.
•
Monitors the adequacy of our capital and liquidity positions.
|
COMPENSATION COMMITTEE
•
Oversees risks relating to our compensation programs and strategies for attracting, motivating and retaining employees and aligning their interests with the best interest of the firm.
|
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
•
Oversees risk relating to the effectiveness of our Board, the quality of leadership, and succession planning.
|
||||||||||||
|
|
||||||||||||||
|
LEADERSHIP TEAM
•
With the guidance and oversight of the Board and its committees, management of day-to-day judgments on risk matters throughout the business has been delegated to the leadership team.
|
||||||||||||||
|
20
|
CARLYLE
Proxy Statement 2022
|
||||
|
CYBERSECURITY BEST PRACTICES
|
|||||||||||
|
•
Multi-factor authentication for remote access; privileged access management for system administrators; application whitelisting; laptop encryption; and advanced malware defenses on endpoints
•
Incident preparedness (e.g., Incident Response (IR) Plan, IR Retainer, IR Playbooks, and testing) and risk transfer via Cyber Insurance
•
Independent & continuous security testing, assessment, and vulnerability management
•
Cyber Third-Party Risk Management
•
Security awareness training, including phishing simulations, for all Carlyle personnel and contractors, as well as additional training for GTS employees regarding cyber best practices
•
Restrictions on access to personal email accounts; cloud storage; social media, and USB storage devices
|
|||||||||||
|
Carlyle uses the NIST Cybersecurity Framework as a model for understanding and shaping its cyber security program and is a member of the Financial Services Information Sharing and Analysis Center.
|
|||||||||||
|
CARLYLE
Proxy Statement 2022
|
21
|
||||
|
22
|
CARLYLE
Proxy Statement 2022
|
||||
| AUDIT COMMITTEE | |||||||||||
|
Members
William J. Shaw (Chair)
Lawton W. Fitt
Derica Rice
Dr. Thomas S. Robertson
Meetings in 2021: 10
|
Principal Responsibilities:
The purpose of the Audit Committee is to provide assistance to the Board of Directors in fulfilling its obligations with respect to matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions, including, without limitation, assisting the board of director’s oversight of:
•
the quality and integrity of our financial statements,
•
our compliance with legal and regulatory requirements,
•
our independent registered public accounting firm’s qualifications and independence, and
•
the performance of our independent registered public accounting firm and our internal audit function, and directly appointing, retaining, reviewing and terminating our independent registered public accounting firm.
The members of our Audit Committee have not participated in the preparation of our financial statements at any time during the past three years and meet the and financial literacy requirements for service on an Audit Committee of a Board of Directors pursuant to the Nasdaq Listing Rules relating to corporate governance matters. The Board of Directors has determined that Mr. Shaw is an “audit committee financial expert” within the meaning of Item 407(d)(5) of Regulation S-K. The Audit Committee has a charter which is available on our website at
http://ir.carlyle.com
.
|
||||||||||
| COMPENSATION COMMITTEE | |||||||||||
|
Members
Anthony Welters (Chair)
Lawton W. Fitt
Mark S. Ordan
Derica Rice
Meetings in 2021: 6
|
Principal Responsibilities:
Our Compensation Committee is responsible for, among other duties and responsibilities:
•
reviewing and approving all forms of compensation to be provided to, and employment agreements with, our Chief Executive Officer,
•
establishing and reviewing our overall compensation philosophy, and reviewing, approving, and
•
overseeing the administration of our equity incentive plan. In fulfilling its responsibilities, the Compensation Committee may delegate any or all of its responsibilities to a subcommittee of the Compensation Committee.
The Compensation Committee may also delegate to one or more officers of the Company the authority to make certain grants and awards to employees of the Company or its affiliates under the Company’s equity incentive plan as the Compensation Committee deems appropriate and in accordance with the terms of such plan; provided that such delegation is in compliance with the plan and the laws of the state of Delaware.
The Compensation Committee has a charter which is available on our website at
http://ir.carlyle.com
.
|
||||||||||
|
CARLYLE
Proxy Statement 2022
|
23
|
||||
|
NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
|
|||||||||||
|
Members
Lawton W. Fitt (Chair)
Linda H. Filler
Anthony Welters
Meetings in 2021: 5
|
Principal Responsibilities:
Our Nominating and Corporate Governance Committee is responsible for, among its other duties and responsibilities:
•
identifying candidates qualified to serve on our Board of Directors,
•
reviewing the composition of the Board of Directors and its committees,
•
developing and recommending to the Board of Directors corporate governance principles that are applicable to us, and
•
overseeing the evolution of the Board of Directors.
The Nominating and Corporate Governance Committee has a charter which is available on our website at
http://ir.carlyle.com
.
|
||||||||||
|
24
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
25
|
||||
|
||
|
The Board unanimously recommends a vote
“FOR”
the ratification of the selection of Ernst & Young as our independent registered public accounting firm.
|
||
|
26
|
CARLYLE
Proxy Statement 2022
|
||||
|
Year Ended December 31, 2021
|
|||||||||||||||||||||||
| The Carlyle Group Inc. | Carlyle Funds | Total | |||||||||||||||||||||
| Audit Fees | $ | 6.2 |
(a)
|
$ | 22.3 |
(d)
|
$ | 28.5 | |||||||||||||||
| Audit-Related Fees | 1.5 |
(b)
|
33.8 |
(e)
|
35.3 | ||||||||||||||||||
| Tax Fees | 4.1 |
(c)
|
1.3 |
(d)
|
5.4 | ||||||||||||||||||
| All Other Fees | — | — | — | ||||||||||||||||||||
| Total | $ | 11.8 | $ | 57.4 | $ | 69.2 | |||||||||||||||||
|
Year Ended December 31, 2020
|
|||||||||||||||||||||||
| The Carlyle Group Inc. | Carlyle Funds | Total | |||||||||||||||||||||
| Audit Fees | $ | 5.4 |
(a)
|
$ | 19.9 |
(d)
|
$ | 25.3 | |||||||||||||||
| Audit-Related Fees | 0.1 |
(b)
|
16.1 |
(e)
|
16.2 | ||||||||||||||||||
| Tax Fees | 4.8 |
(c)
|
0.3 |
(d)
|
5.1 | ||||||||||||||||||
| All Other Fees | — | — | — | ||||||||||||||||||||
| Total | $ | 10.3 | $ | 36.3 | $ | 46.6 | |||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
27
|
||||
|
William J. Shaw
Lawton W. Fitt
Derica W. Rice
Dr. Thomas S. Robertson
|
|||||
|
28
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
| Name | Age | Position | ||||||||||||
| Kewsong Lee | 56 | Chief Executive Officer and Director | ||||||||||||
| Curtis L. Buser | 58 | Chief Financial Officer | ||||||||||||
| Peter J. Clare | 57 | Chief Investment Officer of Corporate Private Equity, Chairman of the Americas and Director | ||||||||||||
| Jeffrey W. Ferguson | 56 | General Counsel | ||||||||||||
| Christopher Finn | 64 | Chief Operating Officer | ||||||||||||
| Bruce M. Larson | 59 | Chief Human Resources Officer | ||||||||||||
|
CARLYLE
Proxy Statement 2022
|
29
|
||||
|
30
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
|
The Board recommends a vote
“FOR”
the approval of the compensation of our named executive officers.
|
||
|
CARLYLE
Proxy Statement 2022
|
31
|
||||
|
KEWSONG
LEE |
|
CURTIS L.
BUSER |
|
PETER J.
CLARE |
||||||||||||
| Chief Executive Officer and Principal Executive Officer | Chief Financial Officer and Principal Financial Officer | Chief Investment Officer of Corporate Private Equity and Chairman of the Americas | |||||||||||||||
|
CHRISTOPHER
FINN |
|
BRUCE
LARSON |
||||||||||||||
| Chief Operating Officer | Chief Human Resources Officer | ||||||||||||||||
| CD&A HIGHLIGHTS | ||||||||||||||||||||
| COMPENSATION PHILOSOPHY | COMPENSATION DECISION-MAKING PROCESS |
COMPENSATION ELEMENTS
|
COMPENSATION GOVERNANCE PRACTICES | |||||||||||||||||
| Page | 34 | 35 | 36 | 49 | ||||||||||||||||
| Section Highlights |
Compensation Objectives
Elements that Discourage Risk-Taking
|
Compensation Decisions
Compensation Consultants
Review of Reference Companies
|
Overview of Elements
Base Salary
Annual Cash Performance Awards
Long-Term Equity Awards
Other 2021 Compensation Opportunities (Including Carried Interest)
2022 Compensation Opportunities
|
Policy Against Hedging and General Prohibition Against Pledging
Clawback Policy
Executive Stock Ownership Guidelines
Perquisites
Tax and Accounting Considerations
|
||||||||||||||||
|
32
|
CARLYLE
Proxy Statement 2022
|
||||
|
WHAT WE DO:
|
WHAT WE DO NOT DO:
|
||||||||||||||||
Align pay with firmwide performance, including through use of time-vesting and performance-vesting RSUs
Large majority of compensation is variable, and the majority is delivered in equity
Long-term incentive awards are denominated and settled in equity
Prohibit short sales and derivative transactions in our equity and hedging of our stock and generally prohibit pledging of our stock
Regularly engage with current and potential shareholders
Engage an independent compensation consultant that works directly for our Compensation Committee and does no work for management
Tie incentive compensation to a clawback policy that covers financial restatements
Require our executive officers to own a minimum value of shares of our common stock
Hold an annual Say-on-Pay vote
Perform an annual compensation risk assessment
Require performance at the 66th percentile of relative TSR in order to receive the target payout under our CEO’s TSR-based outperformance awards, and provide for forfeiture of such awards for performance below the 50th percentile of relative TSR
For new equity incentive awards granted in 2022, require a qualifying termination of employment following a change in control of Carlyle in order for any such change in control to trigger accelerated vesting rights
|
No excise tax “gross-up” payments in the event of a change in control
No tax “gross-up” payment in perquisites for named executive officers
No dividends or dividend equivalents accrued or paid on unvested equity awards
No supplemental executive retirement benefits.
|
||||||||||||||||
| ANNUAL CASH PERFORMANCE AWARDS | LONG-TERM EQUITY AWARDS | ||||||||||||||||||||||||||||||||||
| CEO | OTHER NAMED EXECUTIVE OFFICERS | CEO | OTHER NAMED EXECUTIVE OFFICERS* | ALL NAMED EXECUTIVE OFFICERS | |||||||||||||||||||||||||||||||
|
FORMULAIC BONUS
|
PERFORMANCE BONUS
|
PERFORMANCE BONUS
|
2018-2022 PERFORMANCE-VESTING RSUs
Fourth Installment
|
PERFORMANCE-VESTING RSUs |
PERFORMANCE-VESTING RSUs ALIGNED WITH STRATEGIC PLAN
First Installment
|
|||||||||||||||||||||||||||||
|
Annual Dividend
|
Pre-established goals and objectives
|
Assessment of Carlyle performance and individual contributions
|
FRE
RNPR
FEAUM Raised
|
FRE
RNPR
FEAUM Raised
|
FRE
Adjusted FRE for the Global Private Equity segment (Mr. Clare only) |
|||||||||||||||||||||||||||||
|
$2.5M
|
Maximum
|
Range of $2.75M -$3M | 200% | 200% | Target achieved | |||||||||||||||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
33
|
||||
| SAY-ON-PAY |
With respect to our 2021 non-binding, advisory say-on-pay vote, over 91% of our shareholders approved the compensation of our named executive officers as described in our
Proxy Statement for our 2021 Annual Meeting of Shareholders
. Based on this level of support, the Compensation Committee determined that shareholders generally support our pay practices and the named executive officers’ compensation levels. Accordingly, our approach to executive compensation for fiscal 2021 remained consistent with past practice. However, based on feedback, we implemented an incentive compensation clawback policy and executive stock ownership guidelines during fiscal 2021.
|
||||
|
|||||
|
34
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
35
|
||||
| Compensation Element | Description | Purpose and Alignment | ||||||||||||
| Cash | ||||||||||||||
|
BASE SALARY
|
Fixed salary paid bi-weekly to our executives | Provides a base compensation floor, but is not intended to be a significant element of compensation for our executives | ||||||||||||
|
FORMULAIC AND PERFORMANCE-BASED CASH BONUSES FOR CEO
|
Bonus paid in cash with 2 components: (1) formulaic bonus calculated with reference to the annual dividend paid to shareholders in respect of a calendar year times 2.5 million and (2) incentive bonus with a maximum value of up to 120% of the formulaic bonus based on goals determined and evaluated annually by the Compensation Committee (including the achievement of certain strategic initiatives, employee engagement, leadership and exemplification of the values of our firm, succession planning, diversity and inclusion and ESG efforts and FRE margin improvement) | (1) Formulaic component aligns the CEO with the interests of our shareholders and (2) incentive portion of the bonus rewards achievement of goals formulated to drive key business priorities | ||||||||||||
|
CASH BONUS FOR OTHER NAMED EXECUTIVE OFFICERS
|
Annual bonus paid in cash and determined based on overall firm, investment fund and individual performance | Rewards achievement of key strategic priorities and goals | ||||||||||||
| Long Term Incentives | ||||||||||||||
|
TIME-VESTING RESTRICTED STOCK UNITS
|
Time-vesting RSU awards for Messrs. Buser, Finn and Larson that are eligible to vest over 3.5 to 4 years. | Align interests of our executives with those of our shareholders, promote share ownership for our leadership team and promote retention since in most cases shares are forfeited if the executive leaves before vesting | ||||||||||||
|
PERFORMANCE-VESTING RESTRICTED STOCK UNITS
|
Performance-vesting RSU awards for our CEO and other named executive officers that vest based on achievement of one or more financial performance metrics (FRE, RNPR, FEAUM Raised and Adjusted FRE for the Global Private Equity segment), with certain of such awards eligible to vest at threshold (50%), target (100%) or maximum (200%) based on achievement, and with the payout of certain of such awards capped at 150% if certain stock price conditions are not satisfied. | Drive executive performance to create value for our shareholders by providing a significant at-risk compensation element and aligning our executives’ interest with those of our shareholders | ||||||||||||
|
36
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
37
|
||||
| Performance Considerations | |||||
|
Strategic initiatives
•
Accelerated the growth of our Global Credit segment, including progress on new initiatives and acquisitions
•
Consolidated and integrated our Capital Markets team, helping drive more revenue from capital markets
•
Raised a record $51.3 billion in new commitments across our three global business segments (an increase of 87% over 2020), which included the launch of 11 funds across our platform, strong CLO fundraising in Global Credit, and significant growth in the separately managed accounts in Global Investment Solutions;
•
Continued to strategically innovate and differentiate our business lines and product offerings to drive growth, resulting in total assets under management exceeding $300 billion for the first time;
•
Aligned our people with our stockholders and the firm’s overall success, including through the launch of the Distributing a Portion of Realized Carry in Shares Program
|
|||||
|
Employee Engagement, Leadership and Exemplification of the Values of our Firm
•
Strengthened and expanded our talent development, training and employee retention programs
•
Continued our employee engagement survey, which reflected improved employee satisfaction
•
Rolled out enhanced leadership development programs and implemented a well-being strategy focused on emotional, physical, financial, environmental and social well-being
|
|||||
|
Diversity and Inclusion and ESG Efforts
•
Expanded our ESG efforts, including by completing more than $12 billion in ESG-linked financings for Carlyle and our portfolio companies, and co-leading the creation of the ESG Data Convergence Project, the first-ever General Partner/Limited Partner collaboration to align on a set of standardized ESG metrics, which now has over 100 GP and LP participants;
•
Further increased our focus on diversity, equity and inclusion initiatives, including by launching our inaugural Diversity, Equity and Inclusion Incentive Awards that recognized over 50 employees for their effort in advancing Carlyle’s DEI objectives;
•
Created more accountability with DEI objectives and employee goal setting
|
|||||
|
FRE Margin Improvement
•
Full-year FRE margin grew to 33%, up from 30% in 2020 (excluding the impact of a one-time litigation cost recovery in 2020)
|
|||||
|
Succession Planning
•
Identified key internal leaders and invested in their development
•
Recruited and hired senior-level professionals to provide new perspectives
|
|||||
|
38
|
CARLYLE
Proxy Statement 2022
|
||||
| Name | Performance Considerations | 2021 Bonus | ||||||||||||
| Curtis Buser | In assessing Mr. Buser’s performance, the CEO considered his oversight of our accounting, finance and treasury functions, his leadership role in continuing our business in a remote and hybrid work environment and guiding our policies regarding reopening our global offices, as well as his management of our balance sheet and focus on managing costs. | $2,750,000 | ||||||||||||
| Peter Clare | In assessing Mr. Clare’s performance, the CEO considered his leadership in driving investment fund performance to create value for our investors in his roles as Chief Investment Officer of Corporate Private Equity and Chairman of Americas Private Equity. | $3,000,000 | ||||||||||||
| Christopher Finn | In assessing Mr. Finn’s performance, the CEO considered his leadership and oversight of our operations across the firm’s global platform, his leadership role in transitioning our business to a hybrid work environment and guiding our policies regarding reopening our global offices, as well as his role in working to streamline and enhance the efficiency of the firm’s processes and operations. | $2,750,000 | ||||||||||||
| Bruce Larson | In assessing Mr. Larson’s performance, the CEO considered his leadership and oversight of our succession planning, talent management, training and development and compensation for the employees of the firm, as well as his continuing commitment to furthering our DEI objectives. | $2,750,000 | ||||||||||||
| Name | Number of Time-Vesting RSUs |
Number of Performance Vesting RSUs
(Target)
|
|||||||||
| Kewsong Lee | 1,250,000 | 1,250,000 | |||||||||
|
CARLYLE
Proxy Statement 2022
|
39
|
||||
| Grant Date | February 1, 2018 | ||||
| Terms |
The time-vesting RSUs are generally eligible vest in equal installments over five years on February 1 of each year, subject to the continued employment of Mr. Lee on each applicable vesting date.
|
||||
| Grant Date | February 6, 2018 | ||||
| Terms |
The performance-vesting RSUs generally will be eligible to vest and settle annually in five equal target installments, subject to Mr. Lee’s continued employment on the applicable vesting date, with the opportunity to earn between 0% and 200% of the target amount of the performance-vesting RSUs based on the level of achievement of specified performance metrics that will be set by our Compensation Committee at the beginning of each performance year, subject to a cap of 150% if the volume weighted average price of the Company’s common stock over the 30 consecutive trading-day period ending on the last day of the applicable performance period is less than or equal to the volume weighted average price of the Company’s common stock for the 30 consecutive trading-day period ending on the date on which the underlying performance goals for such performance period were approved, which is referred to herein as the “Share Price Governor.”
|
||||
| Performance Metrics | Weighting | How Goals are Calculated | ||||||
| Fee Related Earnings (“FRE”) | 50% | FRE is described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Financial Measures—Non-GAAP Financial Measures—Fee Related Earnings” in our Annual Report on Form 10-K. | ||||||
| Realized Net Performance Revenues (“RNPR”) | 25% | RNPR is described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K | ||||||
| Fee-Earning Assets Under Management Raised (“FEAUM Raised”) | 25% | FEAUM Raised represents fee earning capital raised from limited partners and excludes capital commitments made by the firm or through our internal coinvestment program. | ||||||
|
40
|
CARLYLE
Proxy Statement 2022
|
||||
| Goal |
Weight
|
Performance Required
|
% Earned | Weighted Payout | |||||||||||||||||||||||||||||||
|
Threshold
(50% of Target Payout)
|
Target
(100% of Target
Payout)
|
Maximum
(200%* of Target
Payout)
|
|||||||||||||||||||||||||||||||||
| FRE | 50% |
|
200% | 100% | |||||||||||||||||||||||||||||||
| RNPR | 25% |
|
200% | 50% | |||||||||||||||||||||||||||||||
| FEAUM Raised | 25% |
|
200% | 50% | |||||||||||||||||||||||||||||||
| Final Weighted Achievement Factor: | 200% | ||||||||||||||||||||||||||||||||||
|
Shares:
|
Number of Shares Delivered: | 500,000 | |||||||||||||||||||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
41
|
||||
| Name |
Outperformance Award (Target Number of RSUs)
|
||||
| Kewsong Lee | 500,000 | ||||
| Grant Date | February 13, 2019 | ||||
| Terms |
The additional performance-vesting RSUs generally will vest and settle at the end of the four-year cumulative performance period, subject to Mr. Lee’s continued employment, with the opportunity to earn between 0% and a maximum of 150% of the target amount of the performance-vesting RSUs based on outperformance against two total shareholder return (“TSR”) measures. In order to receive a payout, over the four-year cumulative performance period Carlyle must achieve both an absolute TSR of not less than 6% per annum and relative outperformance on TSR growth measured as shown below:
|
||||
|
4-Year Relative TSR v.
S&P 500 Financials |
% Earned
(1)
|
|||||||
| Less than 50th Percentile | 0% | |||||||
| 50th Percentile | 50% | |||||||
| 66th Percentile | 100% | |||||||
| ≥ 75th Percentile | 150% | |||||||
|
(1)
Interpolation used for payouts between 50th and 66th or between 66th and 75th percentiles above
|
||||||||
| Name |
Outperformance Award (Target Number of RSUs)
|
||||
| Kewsong Lee | 100,000 | ||||
| Grant Date | February 12, 2020 | ||||
| Terms |
The additional performance-vesting RSUs generally will vest and settle at the end of a three-year cumulative performance period, subject to Mr. Lee’s continued employment, with the opportunity to earn between 0% and a maximum of 150% of the target amount of the performance-vesting RSUs based on outperformance against the same absolute and relative TSR measures as the 2019 four-year outperformance award, but applied to the 2020-2022 performance period. In order to receive a payout, over the three-year cumulative performance period Carlyle must achieve both an absolute TSR of not less than 6% per annum and relative outperformance on TSR growth measured as shown above.
|
||||
|
42
|
CARLYLE
Proxy Statement 2022
|
||||
| Name | Performance Considerations | Target Value of Time-Vesting RSUs |
Target Value of Performance-Vesting RSUs
|
|||||||||||
| Curtis Buser | Mr. Buser received his grants due to his strong performance during 2020 as our Chief Financial Officer, including his oversight of our accounting, finance and treasury functions, his leadership role in our conversion to a corporation and his management of our balance sheet including through our senior notes offering and redemption of preferred units. | $1,750,000 | $1,750,000 | |||||||||||
| Christopher Finn | Mr. Finn received his grant due to his strong performance during 2020 as our Chief Operating Officer, including his leadership and oversight of our operations across the firm’s global platform and his management of the strategic transformation of our processes and operations to further enhance the capabilities of our teams. | $1,750,000 | $1,750,000 | |||||||||||
| Bruce Larson | Mr. Larson received his grant due to his strong performance during 2020 as our Chief Human Resources Officer, including his leadership as we converted to a fully remote environment at the onset of the COVID-19 pandemic. | $1,250,000 | — | |||||||||||
| Grant Date | February 1, 2021 | ||||
| Terms |
The time-vesting RSUs will be eligible to vest 40% on August 1, 2022, 30% on August 1, 2023 and 30% on August 1, 2024, subject to the applicable named executive officer’s continued employment through each applicable vesting date.
|
||||
| Grant Date | February 2, 2021 | ||||
| Terms |
The performance-vesting RSUs were eligible to vest subject to achievement of the same performance targets and weightings, and subject to the same Share Price Governor, in each case as were applicable to the fourth installment of Mr. Lee’s performance-vesting RSUs as described above under “—Settlement of Fourth (2021) Installment of Performance-Vesting RSUs.”
|
||||
| Achievement |
Accordingly, the final weighted achievement factor for the awards for Messrs. Buser and Finn also was at 200% of target, which resulted in each of them earning 131,878 shares of common stock following certification of the attainment of the applicable performance metrics on February 8, 2022.
|
||||
|
CARLYLE
Proxy Statement 2022
|
43
|
||||
| Name | Performance Considerations | Target Value of Time-Vesting RSUs |
Target Value of Performance-Vesting RSUs
|
|||||||||||
| Curtis Buser | In assessing Mr. Buser’s performance, the CEO considered his oversight of our accounting, finance and treasury functions, his leadership role in continuing our business in a remote and hybrid work environment and guiding our policies regarding reopening our global offices, as well as his management of our balance sheet and focus on managing costs. | $1,750,000 | $1,750,000 | |||||||||||
| Christopher Finn | In assessing Mr. Finn’s performance, the CEO considered his leadership and oversight of our operations across the firm’s global platform, his leadership role in transitioning our business to a hybrid work environment and guiding our policies regarding reopening our global offices, as well as his role in working to streamline and enhance the efficiency of the firm’s processes and operations. | $1,750,000 | $1,750,000 | |||||||||||
| Bruce Larson | In assessing Mr. Larson’s performance, the CEO considered his leadership and oversight of our succession planning, talent management, training and development and compensation for the employees of the firm, as well as his continuing commitment to furthering our DEI objectives. | $1,750,000 | $1,750,000 | |||||||||||
| GRANT DATE | February 1, 2022 | ||||
| Terms |
These time-vesting RSUs are eligible to vest 40% on August 1, 2023, 30% on August 1, 2024 and 30% on August 1, 2025, subject to the applicable named executive officer’s continued employment through the applicable vesting date.
|
||||
| GRANT DATE | February 8, 2022 | ||||
| Terms |
These performance-vesting RSUs will be eligible to vest subject to the achievement of the same performance targets and weightings, and subject to the same Share Price Governor, in each case as are applicable to the fifth installment of Mr. Lee’s performance-vesting RSUs as described above under “—CEO Equity Awards—2018-2022 RSUs—Fifth (2022) Installment of Performance-Vesting RSUs.”
|
||||
|
44
|
CARLYLE
Proxy Statement 2022
|
||||
| Name | Number of Strategic Equity Time-Vesting RSUs |
Number of Strategic Equity Performance-Vesting RSUs
|
|||||||||
| Kewsong Lee | — | 928,040 | |||||||||
| Curtis Buser | 116,005 | 116,005 | |||||||||
| Peter Clare | — | 464,020 | |||||||||
| Christopher Finn | 116,005 | 116,005 | |||||||||
| Bruce Larson | 116,005 | 116,005 | |||||||||
| GRANT DATE | February 2, 2021 | ||||
| Terms |
The Strategic Equity time-vesting RSUs vested 20% on February 1, 2022 and are eligible to vest 20% on February 1, 2023, 20% on February 1, 2024 and 40% on February 1, 2025, subject in each case to the applicable named executive officer’s continued employment through each applicable vesting date.
|
||||
| GRANT DATE | February 1, 2022 | ||||
| Terms |
The Strategic Equity performance-vesting RSUs are generally eligible to vest 20% in February 2022 (and did vest, as described below), 20% in February 2023, 20% in February 2024 and 40% in February 2025 subject to, in the case of the awards made to Messrs. Buser, Finn, Larson and Lee, achievement of Company FRE metrics relating to the strategic plan and, in the case of the award made to Mr. Clare, achievement of FRE metrics for the Company (which relate to 25% of Mr. Clare’s award) and adjusted FRE metrics for the Company’s Global Private Equity segment (which relate to 75% of Mr. Clare’s award), in each case relating to the strategic plan.* There is no outperformance opportunity in respect of the Strategic Equity performance-vesting RSUs; the maximum number of RSUs each named executive officer is eligible to vest in is the number of RSUs granted to such named executive officer.
|
||||
| Achievement – First Installment |
On February 8, 2022, following certification that the FRE target of $475 million for the 2021 performance year was achieved and, with respect to Mr. Clare, that the Global Private Equity segment’s adjusted FRE target for the 2021 performance year of $255 million was achieved, 20% of the performance-based strategic equity awards granted to our named executive officers vested, resulting in the delivery of 23,201, 92,804, 23,201, 23,201 and 185,608 shares of common stock to Messrs. Buser, Clare, Finn, Larson and Lee, respectively.
|
||||
|
CARLYLE
Proxy Statement 2022
|
45
|
||||
| Goal |
Performance Required
|
Earned | |||||||||||||||
|
Target (100% of Target Payout)
|
|||||||||||||||||
| FRE |
|
Achieved | |||||||||||||||
|
Adjusted FRE for Global
Private Equity Segment (Mr. Clare only) |
|
Achieved | |||||||||||||||
|
46
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
47
|
||||
| Name | Prior Base Salary | 2022 Base Salary | ||||||||||||
| Kewsong Lee | $275,000 | $1,000,000 | ||||||||||||
| Curtis Buser | $275,000 | $500,000 | ||||||||||||
| Peter Clare | $275,000 | $500,000 | ||||||||||||
| Christopher Finn | $275,000 | $500,000 | ||||||||||||
| Bruce Larson | $275,000 | $500,000 | ||||||||||||
|
48
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
49
|
||||
|
50
|
CARLYLE
Proxy Statement 2022
|
||||
|
Anthony Welters
William E. Conway, Jr.
Lawton W. Fitt
|
|||||
|
CARLYLE
Proxy Statement 2022
|
51
|
||||
| Name and Principal Position | Year | Salary ($) |
Cash Bonus
($)
|
Stock Awards
($)(2)
|
All Other
Compensation
($)
|
Total
($)
|
|||||||||||||||||||||||||||||
| Kewsong Lee | 2021 | 275,000 | 5,500,000 |
(1)
|
36,110,256 | 437,245 |
(3)
|
42,322,501 | |||||||||||||||||||||||||||
| Chief Executive Officer (principal executive officer) | 2020 | 275,000 | 5,500,000 | 10,274,286 | 334,917 | 16,384,203 | |||||||||||||||||||||||||||||
| 2019 | 275,000 | 5,900,000 | 9,563,295 | 315,285 | 16,053,580 | ||||||||||||||||||||||||||||||
| Curtis L. Buser | 2021 | 275,000 | 2,750,000 | 11,149,577 | 54,384 |
(4)
|
14,228,961 | ||||||||||||||||||||||||||||
| Chief Financial Officer (principal financial officer) | 2020 | 275,000 | 2,500,000 | 3,965,860 | 30,847 | 6,771,707 | |||||||||||||||||||||||||||||
| 2019 | 275,000 | 2,500,000 | 3,322,287 | 19,800 | 6,117,087 | ||||||||||||||||||||||||||||||
| Peter J. Clare | 2021 | 275,000 | 3,000,000 | 14,058,878 | 58,738,149 |
(5)
|
76,072,027 | ||||||||||||||||||||||||||||
| Chief Investment Officer of Corporate Private Equity and Chairman of the Americas | 2020 | 275,000 | 2,750,000 | — | 7,028,785 | 10,053,785 | |||||||||||||||||||||||||||||
| 2019 | 275,000 | 2,500,000 | — | 656,445 | 3,431,445 | ||||||||||||||||||||||||||||||
| Christopher Finn | 2021 | 275,000 | 2,750,000 | 11,149,577 | 1,477,717 |
(6)
|
15,652,294 | ||||||||||||||||||||||||||||
| Chief Operating Officer | 2020 | 275,000 | 2,500,000 | 3,965,860 | 560 | 6,741,420 | |||||||||||||||||||||||||||||
| 2019 | 275,000 | 2,500,000 | 3,404,642 | 76,095 | 6,255,737 | ||||||||||||||||||||||||||||||
| Bruce Larson | 2021 | 275,000 | 2,750,000 | 8,477,626 | — | 11,502,626 | |||||||||||||||||||||||||||||
| Chief Human Resources Officer | |||||||||||||||||||||||||||||||||||
|
52
|
CARLYLE
Proxy Statement 2022
|
||||
| Estimated Future Payouts under Equity Incentive Plan Awards |
All Other
Stock Awards:
Number of
Shares of Stock
(#)
|
Grant Date
Fair Value of
Stock and
Option
Awards
($)
|
|||||||||||||||||||||||||||||||||||||||
| Name |
Grant
Date
|
Threshold
(#)
|
Target
(#)
|
Maximum
(#)
|
|||||||||||||||||||||||||||||||||||||
| Kewsong Lee | |||||||||||||||||||||||||||||||||||||||||
|
Performance-Vesting RSUs
(1)
|
|
2/2/2021 | 125,000 | 250,000 | 500,000 | — | $ | 7,992,500 | |||||||||||||||||||||||||||||||||
|
Strategic Equity Performance-Vesting RSUs
(2)
|
|
2/2/2021 | — | 928,040 | — | $ | 28,117,756 | ||||||||||||||||||||||||||||||||||
| Curtis L. Buser | |||||||||||||||||||||||||||||||||||||||||
|
Annual Time-Vesting RSUs
(4)
|
|
2/1/2021 | — | — | — | 65,939 | $ | 1,973,554 | |||||||||||||||||||||||||||||||||
|
One-Year Performance-Vesting RSUs
(1)
|
|
2/2/2021 | 32,970 | 65,939 | 131,878 | — | $ | 2,108,070 | |||||||||||||||||||||||||||||||||
|
Strategic Equity Time-Vesting RSUs
(3)
|
|
2/2/2021 | 116,005 | $ | 3,553,233 | ||||||||||||||||||||||||||||||||||||
|
Strategic Equity Performance-Vesting RSUs
(2)
|
|
2/2/2021 | — | 116,005 | — | — | $ | 3,514,720 | |||||||||||||||||||||||||||||||||
| Peter J. Clare | |||||||||||||||||||||||||||||||||||||||||
|
Strategic Equity Performance-Vesting RSUs
(2)
|
|
2/2/2021 | — | 464,020 | — | $ | 14,058,878 | ||||||||||||||||||||||||||||||||||
| Christopher Finn | |||||||||||||||||||||||||||||||||||||||||
|
Annual Time-Vesting RSUs
(4)
|
|
2/1/2021 | — | — | — | 65,939 | $ | 1,973,554 | |||||||||||||||||||||||||||||||||
|
One-Year Performance-Vesting RSUs
(1)
|
|
2/2/2021 | 32,970 | 65,939 | 131,878 | — | $ | 2,108,070 | |||||||||||||||||||||||||||||||||
|
Strategic Equity Time-Vesting RSUs
(3)
|
|
2/2/2021 | 116,005 | $ | 3,553,233 | ||||||||||||||||||||||||||||||||||||
|
Strategic Equity Performance-Vesting RSUs
(2)
|
|
2/2/2021 | — | 116,005 | — | — | $ | 3,514,720 | |||||||||||||||||||||||||||||||||
| Bruce Larson | |||||||||||||||||||||||||||||||||||||||||
|
Annual Time-Vesting RSUs
(4)
|
|
2/1/2021 | — | — | — | 47,099 | $ | 1,409,673 | |||||||||||||||||||||||||||||||||
|
Strategic Equity Time-Vesting RSUs
(3)
|
|
2/2/2021 | 116,005 | $ | 3,553,233 | ||||||||||||||||||||||||||||||||||||
|
Strategic Equity Performance-Vesting RSUs
(2)
|
|
2/2/2021 | — | 116,005 | — | — | $ | 3,514,720 | |||||||||||||||||||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
53
|
||||
|
54
|
CARLYLE
Proxy Statement 2022
|
||||
| Stock Awards | |||||||||||||||||||||||
|
Number of
Shares or Units
of Stock That Have
Not Vested (#)
|
Market Value
of Shares or Units
of Stock That Have
Not Vested ($)
|
Number of Equity
Incentive Shares or Units
of Stock That Have
Not Vested (#)
(6)
|
Market Value of Equity
Incentive Shares or Units
of Stock That Have
Not Vested ($)
(6)
|
||||||||||||||||||||
| Kewsong Lee |
1,185,608
(1)
|
$ | 65,089,879 |
1,642,432
(6)
|
$ | 90,169,517 | |||||||||||||||||
| Curtis L. Buser |
413,678
(2)
|
$ | 22,710,922 |
92,804
(7)
|
$ | 5,094,940 | |||||||||||||||||
| Peter J. Clare |
217,804
(3)
|
$ | 11,957,440 |
371,216
(8)
|
$ | 20,379,758 | |||||||||||||||||
| Christopher Finn |
399,337
(4)
|
$ | 21,923,601 |
92,804
(7)
|
$ | 5,094,940 | |||||||||||||||||
| Bruce Larson |
163,104
(5)
|
$ | 8,954,410 |
92,804
(7)
|
$ | 5,094,940 | |||||||||||||||||
|
CARLYLE
Proxy Statement 2022
|
55
|
||||
| Stock Awards | |||||||||||
|
Number of Shares
Acquired on Vesting (#)
|
Value Realized
on Vesting ($)
(6)
|
||||||||||
|
Kewsong Lee
(1)
|
572,489 | $ | 20,322,831 | ||||||||
|
Curtis L. Buser
(2)
|
171,416 | $ | 7,631,768 | ||||||||
|
Peter J. Clare
(3)
|
155,000 | $ | 5,547,850 | ||||||||
|
Christopher Finn
(4)
|
156,133 | $ | 6,860,435 | ||||||||
|
Bruce Larson
(5)
|
2,112 | $ | 106,593 | ||||||||
|
56
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
57
|
||||
|
58
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
59
|
||||
| Plan category |
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(1)
|
Weighted-
average
exercise price
of outstanding
options, warrants
and rights
|
Number of
securities remaining
available for future
issuance under equity
compensation plans
(excluding securities
reflected in column)
(2)
|
|||||||||||||||||
| Equity compensation plans approved by security holders | 14,775,651 | — | 15,636,767 | |||||||||||||||||
| Equity compensation plans not approved by security holders | — | — | — | |||||||||||||||||
| Total | 14,775,651 | — | 15,636,767 | |||||||||||||||||
|
60
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
61
|
||||
| Name |
Fees Earned or Paid in Cash
|
Stock
Awards
(1)
|
Total | |||||||||||||||||
|
Linda H. Filler
(2)
|
$ | — | $ | — | $ | — | ||||||||||||||
| Lawton W. Fitt | $ | 170,000 | $ | 162,349 | $ | 332,349 | ||||||||||||||
|
James H. Hance, Jr.
(3)
|
$ | — | $ | — | $ | — | ||||||||||||||
|
Janet Hill
(2)
|
$ | 155,000 | $ | 162,349 | $ | 317,349 | ||||||||||||||
|
Mark S. Ordan
(2)
|
$ | — | $ | — | $ | — | ||||||||||||||
|
Derica W. Rice
(4)
|
$ | 105,979 | $ | 162,349 | $ | 268,328 | ||||||||||||||
| Dr. Thomas S. Robertson | $ | 130,000 | $ | 162,349 | $ | 292,349 | ||||||||||||||
| William J. Shaw | $ | 155,000 | $ | 162,349 | $ | 317,349 | ||||||||||||||
| Anthony Welters | $ | 155,000 | $ | 162,349 | $ | 317,349 | ||||||||||||||
| Stock Awards | ||||||||||||||
| Name |
Number of Shares
or Units of Stock
That Have Not
Vested
|
Market Value of
Shares or Units of
Stock That Have Not
Vested
(1)
|
||||||||||||
|
Linda H. Filler
(2)
|
— | $ | — | |||||||||||
| Lawton W. Fitt | 3,985 | $ | 218,777 | |||||||||||
| Janet Hill | 3,985 | $ | 218,777 | |||||||||||
|
Mark S. Ordan
(2)
|
— | $ | — | |||||||||||
| Derica W. Rice | 3,985 | $ | 218,777 | |||||||||||
| Dr. Thomas S. Robertson | 3,985 | $ | 218,777 | |||||||||||
| William J. Shaw | 3,985 | $ | 218,777 | |||||||||||
| Anthony Welters | 3,985 | $ | 218,777 | |||||||||||
|
62
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
|
CARLYLE
Proxy Statement 2022
|
63
|
||||
|
The Board unanimously recommends a vote
“FOR”
the proposal to provide for the annual election of directors.
|
||
|
64
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
|
CARLYLE
Proxy Statement 2022
|
65
|
||||
|
Kewsong
Lee |
William E.
Conway, Jr. |
Daniel A.
D'Aniello |
David M.
Rubenstein |
Total | |||||||||||||||||||||||||
|
Payments for 2021 Aircraft Use
(1)
|
$ | 1,539,035 | $ | — | $ | — | $ | — | $ | 1,539,035 | |||||||||||||||||||
|
Less: Reimbursable adjustments
(2)
|
451,314 | — | — | — | 451,314 | ||||||||||||||||||||||||
| Total Aircraft Cost for 2021 Business Use | $ | 1,087,721 | $ | — | $ | — | $ | — | $ | 1,087,721 | |||||||||||||||||||
|
66
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
67
|
||||
|
68
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
| Common Stock Beneficially Owned | |||||||||||
| Name of Beneficial Owner | Number | % of Class | |||||||||
|
Carlyle Group Management L.L.C.
(1), (7)
|
154,871,363 | 42.8 | % | ||||||||
|
Capital World Investors
(2)
|
19,315,259 | 5.3 | % | ||||||||
|
The Vanguard Group
(3)
|
18,920,948 | 5.2 | % | ||||||||
|
Morgan Stanley
(4)
|
18,224,322 | 5.0 | % | ||||||||
|
Kewsong Lee
(5), (6)
|
3,034,740 | * | |||||||||
|
Curtis L. Buser
(5)
|
866,105 | * | |||||||||
|
William E. Conway, Jr.
(5)
|
31,999,644 | 8.8 | % | ||||||||
|
Daniel A. D’Aniello
(5), (6)
|
32,999,644 | 9.1 | % | ||||||||
|
David M. Rubenstein
(5)
|
31,249,644 | 8.6 | % | ||||||||
|
Peter J. Clare
(5), (6)
|
5,313,960 | 1.5 | % | ||||||||
|
Jeffrey W. Ferguson
(5)
|
912,987 | * | |||||||||
| Linda H. Filler | — | * | |||||||||
|
Christopher Finn
(5), (6)
|
881,550 | * | |||||||||
|
Lawton W. Fitt
(7)
|
51,930 | * | |||||||||
|
James H. Hance, Jr.
(5), (7)
|
290,375 | * | |||||||||
|
Bruce M. Larson
(5)
|
26,681 | * | |||||||||
| Mark S. Ordan | — | * | |||||||||
|
Derica W. Rice
(6)
|
8,178 | * | |||||||||
|
Thomas S. Robertson
(7)
|
21,930 | * | |||||||||
|
William J. Shaw
(7)
|
51,930 | * | |||||||||
|
Anthony Welters
(7)
|
47,872 | * | |||||||||
|
All executive officers and directors as a group (17 persons)
(7)
|
107,757,170 | 29.8% | |||||||||
|
CARLYLE
Proxy Statement 2022
|
69
|
||||
|
70
|
CARLYLE
Proxy Statement 2022
|
||||
|
||
|
CARLYLE
Proxy Statement 2022
|
71
|
||||
|
||
|
72
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
73
|
||||
|
74
|
CARLYLE
Proxy Statement 2022
|
||||
|
CARLYLE
Proxy Statement 2022
|
75
|
||||
|
76
|
CARLYLE
Proxy Statement 2022
|
||||
| Election of Directors | A plurality of the votes cast (for each director nominee) |
FOR all nominees
Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the election of our director nominees
|
||||||
|
Ratification of Ernst & Young as
our Independent Registered
Public Accounting Firm
|
A majority of the votes cast |
FOR the ratification of the appointment of Ernst & Young
Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the ratification of the appointment
|
||||||
|
Advisory Vote to Approve
Executive Compensation
(Say-on-Pay)
|
A majority of the votes cast |
FOR the resolution approving the Executive Compensation of our named executive officers
Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the resolution
|
||||||
|
Shareholder Proposal to
Reorganize the Board of
Directors into One Class
|
A majority of the votes cast |
FOR the shareholder proposal to reorganize our Board into One Class
Unless a contrary choice is specified, proxies solicited by our Board will be voted FOR the resolution
|
||||||
| Proposal | Voting Options |
Effect of
Abstentions
or Withhold Votes,
as Applicable
|
Broker
Discretionary
Voting Allowed?
|
Effect of Broker
Non-Votes
|
||||||||||
| Election of Directors |
FOR or WITHHOLD (for each director nominee).
|
No effect – will be excluded entirely from the vote with respect to the nominee from which they are withheld | No | No effect | ||||||||||
|
Ratification of Ernst & Young as our Independent Registered Public Accounting Firm
|
FOR, AGAINST or ABSTAIN | No effect — not counted as a “vote cast” | Yes | N/A | ||||||||||
|
Advisory Vote to Approve Executive Compensation (Say-on-Pay)
|
FOR, AGAINST or ABSTAIN | No effect — not counted as a “vote cast” | No | No effect | ||||||||||
|
Shareholder Proposal to Reorganize the Board of Directors into One Class
|
FOR, AGAINST or ABSTAIN | No effect — not counted as a “vote cast” | No | No effect | ||||||||||
|
CARLYLE
Proxy Statement 2022
|
77
|
||||
|
||
| For the Year Ended December 31, 2021 | |||||||||||||||||||||||||||||
| (in millions) |
Total Reportable
Segments |
Consolidated
Funds |
Reconciling
Items |
Carlyle
Consolidated |
|||||||||||||||||||||||||
| Revenues | $ | 4,950.1 | $ | 253.2 | $ | 3,578.8 | (a) | $ | 8,782.1 | ||||||||||||||||||||
| Expenses | $ | 2,706.4 | $ | 217.8 | $ | 1,832.9 | (b) | $ | 4,757.1 | ||||||||||||||||||||
| Other income | $ | — | $ | 2.5 | $ | — | (c) | $ | 2.5 | ||||||||||||||||||||
| Distributable earnings | $ | 2,243.7 | $ | 37.9 | $ | 1,745.9 | (d) | $ | 4,027.5 | ||||||||||||||||||||
| For the Year Ended December 31, 2020 | |||||||||||||||||||||||||||||
| (in millions) |
Total Reportable
Segments |
Consolidated
Funds |
Reconciling
Items |
Carlyle
Consolidated |
|||||||||||||||||||||||||
| Revenues | $ | 2,289.5 | $ | 226.8 | $ | 418.3 | (a) | $ | 2,934.6 | ||||||||||||||||||||
| Expenses | $ | 1,527.4 | $ | 206.2 | $ | 599.7 | (b) | $ | 2,333.3 | ||||||||||||||||||||
| Other income | $ | — | $ | (21.3) | $ | — | (c) | $ | (21.3) | ||||||||||||||||||||
| Distributable earnings | $ | 762.1 | $ | (0.7) | $ | (181.4) | (d) | $ | 580.0 | ||||||||||||||||||||
|
A-1
|
CARLYLE
Proxy Statement 2022
|
||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2021 | 2020 | |||||||||
| Unrealized performance revenues | $ | 3,155.6 | $ | 1,031.0 | |||||||
| Unrealized principal investment income | 351.8 | (556.2) | |||||||||
| Adjusted unrealized principal investment income from investment in Fortitude | — | (104.4) | |||||||||
| Adjustments related to expenses associated with investments in NGP Management and its affiliates | (13.7) | (15.3) | |||||||||
| Tax expense associated with certain foreign performance revenues | 0.2 | 0.5 | |||||||||
| Non-controlling interests and other adjustments to present certain costs on a net basis | 159.6 | 96.6 | |||||||||
| Elimination of revenues of Consolidated Funds | (74.7) | (33.9) | |||||||||
| $ | 3,578.8 | $ | 418.3 | ||||||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2021 | 2020 | |||||||||
| Total Reportable Segments - Fund level fee revenues | $ | 1,794.8 | $ | 1,616.1 | |||||||
|
Adjustments
(1)
|
(127.3) | (130.1) | |||||||||
| Carlyle Consolidated - Fund management fees | $ | 1,667.5 | $ | 1,486.0 | |||||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2021 | 2020 | |||||||||
| Unrealized performance revenues related compensation | $ | 1,549.4 | $ | 432.3 | |||||||
| Equity-based compensation | 172.9 | 116.6 | |||||||||
| Acquisition related charges and amortization of intangibles and impairment | 37.7 | 38.1 | |||||||||
| Tax expense associated with certain foreign performance revenues related compensation | (17.3) | (8.4) | |||||||||
| Non-controlling interests and other adjustments to present certain costs on a net basis | 78.5 | 55.8 | |||||||||
| Right-of-use impairment | 10.2 | — | |||||||||
| Debt extinguishment costs | 26.8 | — | |||||||||
| Other adjustments including severance and C-Corp. conversion costs in 2020 | 14.2 | 8.0 | |||||||||
| Elimination of expenses of Consolidated Funds | (39.5) | (42.7) | |||||||||
| $ | 1,832.9 | $ | 599.7 | ||||||||
|
CARLYLE
Proxy Statement 2022
|
A-2
|
||||
| Year Ended December 31, | |||||||||||
| (in millions, except per share amounts) | 2021 | 2020 | |||||||||
| Income before provision for income taxes | $ | 4,027.5 | $ | 580.0 | |||||||
| Adjustments: | |||||||||||
| Net unrealized performance revenues | (1,606.2) | (598.7) | |||||||||
|
Unrealized principal investment (income) loss
(1)
|
(351.8) | 556.2 | |||||||||
|
Adjusted unrealized principal investment (income) loss from investment in Fortitude
(2)
|
— | 104.4 | |||||||||
|
Equity-based compensation
(3)
|
172.9 | 116.6 | |||||||||
| Acquisition related charges, including amortization of intangibles and impairment | 37.7 | 38.1 | |||||||||
| Tax expense associated with certain foreign performance revenues | (17.1) | (7.9) | |||||||||
| Net income attributable to non-controlling interests in consolidated entities | (70.5) | (34.6) | |||||||||
| Right-of-use asset impairment | 26.8 | — | |||||||||
| Debt extinguishment costs | 10.2 | — | |||||||||
| Other adjustments including severance and C. Corp conversion costs in 2020 | 14.2 | 8.0 | |||||||||
| Distributable Earnings | $ | 2,243.7 | $ | 762.1 | |||||||
|
Realized performance revenues, net of related compensation
(4)
|
1,529.6 | 246.3 | |||||||||
|
Realized principal investment income
(4)
|
209.5 | 73.0 | |||||||||
| Net interest | 93.5 | 76.9 | |||||||||
| Fee Related Earnings | $ | 598.1 | $ | 519.7 | |||||||
| Distributable Earnings | $ | 2,243.7 | $ | 762.1 | |||||||
|
Less: Estimated current corporate, foreign, state and local taxes
(5)
|
457.5 | 39.8 | |||||||||
| Distributable Earnings, net | $ | 722.3 | $ | 722.3 | |||||||
|
Distributable Earnings, net per common share outstanding
(6)
|
$ | 5.01 | $ | 2.05 | |||||||
|
FRE margin
(7)
|
33 | % | 32 | % | |||||||
|
Income before provision for income taxes margin
(8)
|
46 | % | 20 | % | |||||||
|
A-3
|
CARLYLE
Proxy Statement 2022
|
||||
| Year Ended December 31, 2021 | |||||||||||||||||
| (in millions) |
Carlyle
Consolidated |
Adjustments |
Total
Reportable Segments |
||||||||||||||
| Performance revenues | $ | 6,084.6 | $ | (3,146.0) | $ | 2,938.6 | |||||||||||
| Performance revenues related compensation expense | 2,961.0 | (1,552.0) | 1,409.0 | ||||||||||||||
| Net performance revenues | $ | 3,123.6 | $ | (1,594.0) | $ | 1,529.6 | |||||||||||
| Principal investment income (loss) | $ | 637.3 | $ | (427.8) | $ | 209.5 | |||||||||||
| Year Ended December 31, 2020 | |||||||||||||||||
| (in millions) |
Carlyle
Consolidated |
Adjustments |
Total
Reportable Segments |
||||||||||||||
| Performance revenues | $ | 1,635.9 | $ | (1,049.8) | $ | 586.1 | |||||||||||
| Performance revenues related compensation expense | 779.1 | (439.3) | 339.8 | ||||||||||||||
| Net performance revenues | $ | 856.8 | $ | (610.5) | $ | 246.3 | |||||||||||
| Principal investment income (loss) | $ | (540.7) | $ | 613.7 | $ | 73.0 | |||||||||||
|
CARLYLE
Proxy Statement 2022
|
A-4
|
||||
| As of December 31, | ||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Accrued performance allocations, net of accrued giveback obligations | $ | 8,102.8 | $ | 4,949.9 | ||||||||||
| Plus: Accrued performance allocations from NGP Carry Funds | 3.8 | — | ||||||||||||
| Less: Accrued performance allocation-related compensation | (4,087.8) | (2,534.4) | ||||||||||||
| Less: Deferred taxes on certain foreign accrued performance allocations | (55.3) | (56.0) | ||||||||||||
| Less: Net accrued performance allocations attributable to non-controlling interests in consolidated entities | 1.0 | (11.7) | ||||||||||||
| Net accrued performance revenues before timing differences | 3,964.5 | 2,347.8 | ||||||||||||
| Less: Timing differences between the period when accrued performance revenues are realized and the period they are collected/distributed | (70.5) | (16.5) | ||||||||||||
| Net accrued performance revenues attributable to The Carlyle Group Inc. | $ | 3,894.0 | $ | 2,331.3 | ||||||||||
| As of December 31, | |||||||||||
| (in millions) | 2021 | 2020 | |||||||||
| Investments, excluding performance allocations | $ | 2,699.0 | $ | 2,412.3 | |||||||
| Less: Amounts attributable to non-controlling interests in consolidated entities | (220.2) | (214.3) | |||||||||
| Plus: Investments in Consolidated Funds, eliminated in consolidation | 190.5 | 170.8 | |||||||||
|
Less: Strategic equity method investments in NGP Management
(1)
|
(371.8) | (373.5) | |||||||||
| Less: Investment in NGP general partners-accrued performance allocations | (3.8) | — | |||||||||
| Total investments attribution to The Carlyle Group Inc, | 2,293.7 | 1,995.3 | |||||||||
|
Less: CLO loans and other borrowings attributable to The Carlyle Group Inc.
(2)
|
(204.4) | (336.5) | |||||||||
| Total investments attributable to The Carlyle Group Inc., net of CLO loans and other borrowings | $ | 2,089.3 | $ | 1,658.8 | |||||||
|
A-5
|
CARLYLE
Proxy Statement 2022
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|